Manulife (Manufacturers Life Insurance)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $115M | Buy |
2,702,583
+72,970
| +3% | +$3.96M | 0.09% | 218 |
|
|
2026
Q1 | $165M | Buy |
2,629,613
+1,601,237
| +156% | +$128M | 0.14% | 155 |
|
|
2025
Q4 | $98.2M | Sell |
1,028,376
-46,516
| -4% | -$4.56M | 0.08% | 229 |
|
|
2025
Q3 | $105M | Sell |
1,074,892
-83,197
| -7% | -$8.62M | 0.09% | 219 |
|
|
2025
Q2 | $124M | Sell |
1,158,089
-26,826
| -2% | -$2.71M | 0.11% | 176 |
|
|
2025
Q1 | $120M | Buy |
1,184,915
+14,766
| +1% | +$1.49M | 0.11% | 173 |
|
|
2024
Q4 | $105M | Buy |
1,170,149
+49,683
| +4% | +$4.37M | 0.09% | 211 |
|
|
2024
Q3 | $93.9M | Buy |
1,120,466
+20,330
| +2% | +$1.6M | 0.08% | 232 |
|
|
2024
Q2 | $84.7M | Buy |
1,100,136
+54,206
| +5% | +$3.97M | 0.08% | 234 |
|
|
2024
Q1 | $71.6M | Sell |
1,045,930
-58,155
| -5% | -$3.74M | 0.07% | 257 |
|
|
2023
Q4 | $63.8M | Buy |
1,104,085
+19,999
| +2% | +$1.07M | 0.04% | 291 |
|
|
2023
Q3 | $57.2M | Buy |
1,084,086
+14,825
| +1% | +$778K | 0.03% | 298 |
|
|
2023
Q2 | $57.8M | Sell |
1,069,261
-2,603
| -0.2% | -$136K | 0.03% | 299 |
|
|
2023
Q1 | $53.6M | Buy |
1,071,864
+16,563
| +2% | +$781K | 0.03% | 318 |
|
|
2022
Q4 | $48.8M | Sell |
1,055,301
-22,486
| -2% | -$974K | 0.03% | 340 |
|
|
2022
Q3 | $41.7M | Sell |
1,077,787
-9,431
| -0.9% | -$378K | 0.03% | 369 |
|
|
2022
Q2 | $40.5M | Sell |
1,087,218
-45,412
| -4% | -$1.85M | 0.03% | 379 |
|
|
2022
Q1 | $50.2M | Sell |
1,132,630
-503,168
| -31% | -$21.8M | 0.03% | 371 |
|
|
2021
Q4 | $69.5K | Buy |
1,635,798
+273,082
| +20% | +$11.5M | 0.04% | 305 |
|
|
2021
Q3 | $59.1M | Sell |
1,362,716
-422,364
| -24% | -$18.7M | 0.05% | 329 |
|
|
2021
Q2 | $76.3M | Sell |
1,785,080
-249,381
| -12% | -$10.5M | 0.06% | 286 |
|
|
2021
Q1 | $78.6M | Sell |
2,034,461
-306,797
| -13% | -$11.6M | 0.07% | 282 |
|
|
2020
Q4 | $84.2M | Buy |
2,341,258
+795,892
| +52% | +$28.7M | 0.08% | 244 |
|
|
2020
Q3 | $59M | Sell |
1,545,366
-10,585
| -0.7% | -$408K | 0.06% | 290 |
|
|
2020
Q2 | $53.9M | Buy |
1,555,951
+5,816
| +0.4% | +$209K | 0.05% | 306 |
|
|
2020
Q1 | $50.6M | Sell |
1,550,135
-15,258
| -1% | -$596K | 0.06% | 290 |
|
|
2019
Q4 | $70.8M | Buy |
1,565,393
+185,471
| +13% | +$7.76M | 0.07% | 255 |
|
|
2019
Q3 | $55.6M | Sell |
1,379,922
-368,208
| -21% | -$15.6M | 0.06% | 290 |
|
|
2019
Q2 | $75.1M | Buy |
1,748,130
+376,572
| +27% | +$14.5M | 0.09% | 229 |
|
|
2019
Q1 | $52.6M | Buy |
1,371,558
+4,847
| +0.4% | +$185K | 0.06% | 303 |
|
|
2018
Q4 | $48.3M | Sell |
1,366,711
-27,857
| -2% | -$1.01M | 0.06% | 300 |
|
|
2018
Q3 | $53.7M | Sell |
1,394,568
-166,920
| -11% | -$5.83M | 0.06% | 310 |
|
|
2018
Q2 | $51.1M | Sell |
1,561,488
-528,335
| -25% | -$15.9M | 0.06% | 331 |
|
|
2018
Q1 | $57.1M | Buy |
2,089,823
+21,360
| +1% | +$581K | 0.06% | 298 |
|
|
2017
Q4 | $51.3M | Buy |
2,068,463
+12,031
| +0.6% | +$332K | 0.06% | 331 |
|
|
2017
Q3 | $60M | Buy |
2,056,432
+69,606
| +4% | +$1.92M | 0.07% | 273 |
|
|
2017
Q2 | $55.1M | Sell |
1,986,826
-406,405
| -17% | -$10.8M | 0.07% | 291 |
|
|
2017
Q1 | $59.5M | Buy |
2,393,231
+958,828
| +67% | +$23.3M | 0.08% | 272 |
|
|
2016
Q4 | $31M | Sell |
1,434,403
-195,487
| -12% | -$4.27M | 0.04% | 372 |
|
|
2016
Q3 | $38.8M | Sell |
1,629,890
-57,462
| -3% | -$1.37M | 0.06% | 301 |
|
|
2016
Q2 | $39.4M | Buy |
1,687,352
+12,842
| +0.8% | +$278K | 0.06% | 288 |
|
|
2016
Q1 | $31.5M | Buy |
1,674,510
+348,566
| +26% | +$6.12M | 0.03% | 344 |
|
|
2015
Q4 | $24.4K | Sell |
1,325,944
-66,354
| -5% | -$1.19M | 0.02% | 394 |
|
|
2015
Q3 | $22.8K | Buy |
1,392,298
+40,784
| +3% | +$697K | 0.02% | 423 |
|
|
2015
Q2 | $23.9K | Sell |
1,351,514
-10,504
| -0.8% | -$188K | 0.03% | 405 |
|
|
2015
Q1 | $24.2K | Sell |
1,362,018
-33,597
| -2% | -$531K | 0.03% | 396 |
|
|
2014
Q4 | $18.5K | Buy |
1,395,615
+54,122
| +4% | +$692K | 0.03% | 429 |
|
|
2014
Q3 | $15.8K | Sell |
1,341,493
-5,075
| -0.4% | -$63.9K | 0.02% | 468 |
|
|
2014
Q2 | $17.2M | Buy |
1,346,568
+30,268
| +2% | +$394K | 0.03% | 439 |
|
|
2014
Q1 | $17.8K | Buy |
1,316,300
+17,377
| +1% | +$228K | 0.03% | 451 |
|
|
2013
Q4 | $15.6K | Sell |
1,298,923
-164,102
| -11% | -$1.94M | 0.02% | 479 |
|
|
2013
Q3 | $17.2K | Buy |
1,463,025
+38,106
| +3% | +$412K | 0.03% | 442 |
|
|
2013
Q2 | $13.2M | Buy |
+1,424,919
| New | +$12.1M | 0.02% | 469 |
|
Other funds holding BSX
Manulife (Manufacturers Life Insurance)'s BSX Position: Q2 2026 in Review
Manulife (Manufacturers Life Insurance) increased its Boston Scientific (BSX) stake by 2.8% in Q2 2026, buying an estimated $3.96M and bringing the position to 2,702,583 shares worth $115M. The position accounts for 0.09% of the portfolio, ranked #218.
Manulife (Manufacturers Life Insurance) first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $165M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Manulife (Manufacturers Life Insurance) held 2,702,583 shares of Boston Scientific worth $115M as of Q2 2026.
- Manulife (Manufacturers Life Insurance) bought 72,970 Boston Scientific shares in Q2 2026, an estimated $3.96M.
- Boston Scientific made up 0.09% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #218 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Manulife (Manufacturers Life Insurance)'s Boston Scientific position peaked at $165M in Q1 2026.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.